portfolio detail Cornovus Pharmaceuticals

Venture Portfolio

Cornovus Pharmaceuticals

About:
Cornovus Pharmaceuticals has identified a new target and class of agents to treat cardiac failure. The technology, which has been proven in mouse models, delays the onset of heart failure after a heart attack or injury.

CI Representative:
Daniel Wagner
Managing Director, Investments

back to portfolio